Rapid Therapeutic Science Laboratories, Inc. Increase (Decrease) in Other Current Assets
Rapid Therapeutic Science Laboratories, Inc. reported Increase (Decrease) in Other Current Assets of $82.53 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2023-08-14
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in other current assets for the quarter ending 2023-06-30 was $82.53K.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in other current assets for the quarter ending 2023-03-31 was $0.00.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in other current assets for the quarter ending 2022-12-31 was $6.51K.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in other current assets for the quarter ending 2022-09-30 was $6.61K, a 90.80% decline year-over-year.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in other current assets for fiscal 2022 was $6.51K, a 83.66% decline from fiscal 2021.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in other current assets for fiscal 2021 was $39.88K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2023-06-30 | $82.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $82.53K 10-Q · filed 2023-08-14 | $89.04K derived: sum of 3 quarters · filed 2023-08-14 | $95.65K derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 | $6.51K derived: sum of 2 quarters · filed 2023-05-12 | $13.12K derived: sum of 3 quarters · filed 2023-05-12 | $8.75K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | $6.51K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $13.12K derived: sum of 2 quarters · filed 2023-03-30 | $8.75K derived: sum of 3 quarters · filed 2023-08-14 | $6.51K 10-K · filed 2023-03-30 |
| 2022-09-30 | $6.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.23K derived: sum of 2 quarters · filed 2023-08-14 | $0.00 10-Q · filed 2022-11-10 | -$11.96K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | -$4.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$6.61K 10-Q · filed 2023-08-14 | -$18.57K derived: sum of 3 quarters · filed 2023-08-14 | $53.27K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$2.23K 10-Q · filed 2023-05-12 | -$14.19K derived: sum of 2 quarters · filed 2023-05-12 | $57.64K derived: sum of 3 quarters · filed 2023-05-12 | $37.64K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$11.96K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $59.88K derived: sum of 2 quarters · filed 2023-03-30 | $39.88K derived: sum of 3 quarters · filed 2023-03-30 | $39.88K 10-K · filed 2023-03-30 |
| 2021-09-30 | $71.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $51.84K derived: sum of 2 quarters · filed 2022-11-10 | $51.84K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$20.00K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-11 |